Concerns Raised Over Medical Patent Provision

In a recent press release, the Coalition for the Advancement of Medical Research raises concerns over an anti-patent provision in an upcoming appropriations bill. The provision would ban most medical patents pertaining to the field of therapeutic cloning and stem cell research - which would lead to a sharp decline in investment from the largest funders of such research. Less investment means less medical progress towards regenerative medicine for longer, healthier lives. CAMR sees this undebated provision as "a hasty, back-door attempt to stifle therapeutic cloning research."



Post a comment; thoughtful, considered opinions are valued. New comments can be edited for a few minutes following submission. Comments incorporating ad hominem attacks, advertising, and other forms of inappropriate behavior are likely to be deleted.

Note that there is a comment feed for those who like to keep up with conversations.